1 year return (CAGR)
9.06%
PTC Therapeutics Inc Exchange (NASDAQ, USD)
PTCT
66.48
+0.42 (+0.64%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
16.73%
5 year return (CAGR)
8.53%
10 year return (CAGR)
23.26%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.55B
Price/Sales
5.50
Ent value
7.91B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
26.59
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 67.00 |
| Daily high | 67.99 |
| Daily low | 65.91 |
| Daily Volume | 1.02M |
| All-time high | 89.55 |
| 1y analyst estimate | 99.29 |
| Beta | 0.55 |
| EPS (TTM) | -0.42 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| PTCT | S&P500 | |
| Current price drop from All-time high | -25.76% | -2.19% |
| Highest price drop | -94.60% | -56.47% |
| Date of highest drop | 3 Nov 2016 | 9 Mar 2009 |
| Avg drop from high | -45.41% | -10.68% |
| Avg time to new high | 68 days | 12 days |
| Max time to new high | 2688 days | 1805 days |
News
